✦ LIBER ✦

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

✍ Scribed by Dawson, S-J; Makretsov, N; Blows, F M; Driver, K E; Provenzano, E; Le Quesne, J; Baglietto, L; Severi, G; Giles, G G; McLean, C A

Book ID: 110000527
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 578 KB
Volume: 103
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6605736

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BCL2 in breast cancer: a favourable prog

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

✍ Dawson, S-J; Makretsov, N; Blows, F M; Driver, K E; Provenzano, E; Le Quesne, J; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 62 KB

Immunocytochemical localization of BCL-2

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

✍ Julia M. W. Gee; John F. R. Robertson; Ian O. Ellis; Peter Willsher; Richard A. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 824 KB

The protein product of the bcl-2 gene is thought to be involved in inhibition of apoptosis; it may therefore be important in the modulation of hormonal/anti-hormonal responsiveness exhibited by tumours. This study immunocytochemically investigates (i) relationships between bcl-2 protein expression i